Chemoinformaics analysis of DIHYDROXYACETONE PHOSPHATE
| Molecular Weight | 170.057 | nRot | 4 |
| Heavy Atom Molecular Weight | 163.001 | nRig | 3 |
| Exact Molecular Weight | 169.998 | nRing | 0 |
| Solubility: LogS | 0.383 | nHRing | 0 |
| Solubility: LogP | -1.945 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 18.1196 |
| nHD | 3 | BPOL | 18.3344 |
| QED | 0.515 |
| Synth | 4.845 |
| Natural Product Likeliness | 0.786 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.004 |
| HIA | 0.023 |
| CACO-2 | -5.45 |
| MDCK | 0.00130564 |
| BBB | 0.408 |
| PPB | 0.13029 |
| VDSS | 0.41 |
| FU | 0.9163 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.044 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.149 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.126 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.023 |
| CL | 1.578 |
| T12 | 0.954 |
| hERG | 0.018 |
| Ames | 0.63 |
| ROA | 0.012 |
| SkinSen | 0.857 |
| Carcinogencity | 0.062 |
| EI | 0.992 |
| Respiratory | 0.762 |
| NR-Aromatase | 0.001 |
| Antiviral | No |
| Prediction | 0.967083 |